Key Highlights

  • Revenue was USD 99.3 million against an estimate of USD 97.28 million and USD 91.2 million a year earlier.
  • EPS was USD -0.06 against an estimate of USD -0.04, while GAAP diluted loss per share was USD 0.21.
  • Healthcare Solutions Revenue rose 14.4% to USD 48.96 million, driven by dental materials Volume and parts Manufacturing sales.
  • Cash and cash equivalents were USD 91.3 million, with USD 27.1 million in short-term investments, at September 30.

3D Systems Corporation (NYSE:DDD) reported third quarter results that included growth in dental materials and parts manufacturing, two completed divestitures and a restructuring plan adopted in 2025. Revenue was USD 99.3 million, against USD 91.2 million a year earlier and an estimate of USD 97.28 million. EPS was USD -0.06 against an estimate of USD -0.04, while the GAAP net loss attributable to the company was USD 33.5 million, or USD 0.21 per share.

Strategic Priorities and Operating Detail

The company said it does not see significant additional restructuring charges in 2026 from the 2025 Restructuring Plan, which it adopted in response to macroeconomic pressures. It also completed two divestitures from the Industrial Solutions segment: Geomagic, sold on April 1, 2025 for USD 119.4 million in cash, and the 3DXpert and Oqton businesses, sold on October 31, 2025 for USD 3.3 million in cash plus a Royalty receivable with a present value of USD 7.4 million.

Healthcare Solutions revenue was USD 48.96 million against USD 42.79 million, which the company tied to higher dental materials volume, including volume with a key customer, and higher parts manufacturing sales. Industrial Solutions revenue was USD 50.35 million, up 3.9% on higher volume and price/mix, partly offset by divestitures, and product revenue was USD 58.2 million against services revenue of USD 41.1 million.

In the quarter, the company recorded USD 2.9 million of asset Impairment on intangible assets for an Industrial Solutions product line, triggered by a Facility closure.

Quarterly Financial Results

Gross profit was USD 34.8 million, a Margin of 35.0% against 32.3%, which the company linked to higher volume. SG&A expenses were USD 46.4 million against USD 34.7 million, mainly because of USD 12.5 million of litigation expense, while Research and Development fell to USD 10.1 million from USD 16.0 million on restructuring and divestitures. The loss from operations was USD 24.5 million against USD 21.3 million.

The litigation expense relates to a Jury verdict on August 6, 2026 in the Intrepid Automation counterclaims, which found a Subsidiary liable for approximately USD 5.7 million of compensatory damages and USD 6.0 million of exemplary damages. The court has not entered judgment, and the company said it intends to seek post-trial relief and, if necessary, appellate review.

Cash, Debt and Equity

Net cash used in Operating Activities for nine months was USD 17.5 million against USD 73.1 million. In the second quarter, the company issued 18.9 million shares for USD 53.2 million in cash, net of offering costs. Cash and cash equivalents were USD 91.3 million against USD 95.6 million at year end 2025, and short-term investments were USD 27.1 million.

Long-term debt, net of deferred financing costs, was USD 87.9 million, with a current portion of USD 3.9 million. The 5.875% convertible senior secured notes are due in 2030, while the 0% convertible senior notes are scheduled to mature on November 15, 2026, with USD 3.9 million of principal outstanding. No numerical guidance was given.

Next Reporting Checkpoints

Revenue of USD 99.3 million sits alongside a loss from operations of USD 24.5 million, cash of USD 91.3 million and a USD 12.5 million litigation accrual. Management named dated items including the November 15, 2026 Maturity of the remaining USD 3.9 million of 2026 Notes, pending post-trial briefing and judgment in the Intrepid matter, and remediation of material weaknesses in internal controls.